Market Research Reports

Stem Cells Market (Adult, Human Embryonic , Induced Pluripotent, Rat-Neural, Umbilical Cord, Cell Production, Cell Acquisition, Expansion, Sub-Culture) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018

115pages
Published Date: 2013-06-25
 

Description




Stem cells are undifferentiated cells which are capable of differentiating into any type of cell that make-up the human body and thus, are capable of producing non-regenerative cells such as neural and myocardial cells. This report estimates the market for global stem cells in terms of revenue (USD billion) for the period 2012 – 2018, keeping 2011 as the base year. The global stem cells market is mainly segmented into four major sub-types namely market by products, market by technology, market by applications and market by geography.

The market by products is segmented into three sub-types, namely adult stem cells, human embryonic stem cells and other type of stem cells. Adult stem cells are further segmented into hematopoietic stem cells, mesenchymal stem cells, neuronal stem cells, dental stem cells and umbilical cord stem cells. The other types of stem cells include induced pluripotent stem cells, natural rosette cells and very small embryonic like stem cells.

The global stem cells market by technology is segmented into four sub-types, namely cell acquisition, cell production, cryopreservation and expansion and sub-culture. Cell acquisition is further segmented into three sub-types, namely bone marrow harvest, apheresis and umbilical cord blood. Cell production is further segmented into therapeutic cloning, in vitro fertilization, isolation and cell culture.

The global stem cells market by application is segmented into regenerative medicines and drug discovery and development. Regenerative medicines are further segmented into ten sub-types, namely neurological disorders, orthopedics, cancer, hematological disorders, cardiovascular diseases, injuries, diabetes, liver disorders, incontinence and other disorders like Crohn’s disease, infertility, immunodeficiency disorders and organ transplants.

The global stem cells market is also segmented on the basis of geography into North America, Europe, Asia and rest of the world (RoW) regions and the market in terms of USD billion is provided in this report.

The report highlights the market shares of key players in 2011. The company profiles for some of the key players, namely Advanced Cell Technology Inc., STEMCELL Technologies Inc., Cellular Engineering Technologies Inc., BioTime Inc., Aastrom Biosciences Inc. and California Stem Cell Inc. in terms of company overview, financial overview, business strategies, recent developments and product portfolio is also covered.

The global stem cells market is categorized into the following segments:

  • Stem Cells Market by Products
    • Adult Stem Cells
      • Hematopoietic Stem Cells
      • Mesenchymal Stem Cells
      • Neuronal Stem Cells
      • Dental Stem Cells
      • Umbilical Cord Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic Like Stem Cells
  • Stem Cells Market by Technology
    • Cell Acquisition
      • Bone Marrow Harvest
      • Apheresis
      • Umbilical Blood Cord
    • Cell Production
      • Therapeutic Cloning
      • In Vitro Fertilization
      • Isolation
      • Cell Culture
    • Cryopreservation
    • Expansion and Sub-Culture
  • Stem Cells Market by Applications
    • Regenerative Medicine
      • Neurological Disorders
      • Orthopedics
      • Cancer
      • Hematological disorders
      • Cardiovascular diseases
      • Injuries
        • Wound Care
        • Spinal Cord Injury
        • Others (Joint Injuries, Eye Injuries, Lacerations and Concussions)
      • Diabetes
      • Liver Disorder
      • Incontinence
      • Others (Crohn’s Disease, Infertility, Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder)
    • Drug Discovery and Development
  • Stem Cells Market by Geography
    • North America
    • Europe
    • Asia
    • Rest of the World (RoW)

Table of Contents




Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Market Trends and Future Outlook
      3.1.1 Global Stem Cells Market, 2010 – 2018 (USD Billion)
3.2 Market Dynamics
      3.2.1 Market Drivers
               3.2.1.1 Unmet Medical Needs
               3.2.1.2 Increasing Government Support
               3.2.1.3 Growing Medical Tourism
               3.2.1.4 Rising Stem Cells Banking Services
               3.2.1.5 Impact Analysis of the Market Drivers
     3.2.2 Market Restraints
               3.2.2.1 High Cost of Treatment
               3.2.2.2 Government Regulations against Unethical Harvesting of Stem Cells
               3.2.2.3 Impact Analysis of the Market Restraints
     3.2.3 Market Opportunities
               3.2.3.1 Rising Neurodegenerative Disease Patients
               3.2.3.2 Increasing Disposable Income in Emerging Nations
               3.2.3.3 Replacing Animal Tissue in Drug Discovery
               3.2.3.4 Growing Contract Research Industry
     3.2.4 Porter’s Five Forces Analysis for the Global Stem Cells Market
               3.2.4.1 Bargaining Power of Suppliers
               3.2.4.2 Bargaining Power of Buyers
               3.2.4.3 Threat of New Entrants
               3.2.4.4 Threat of Substitutes
      3.2.5 Competitive Rivalry
3.3 Market Attractiveness
      3.3.1 Market Attractiveness Analysis of the Global Stem Cells Market, By Geography

Chapter 4 Global Stem Cells Market, By Products
4.1 Market Segmentation: Global Stem Cells Market, By Products
4.2 Overview
4.3 Adult Stem Cells Market, 2010 – 2018 (USD Billion)
      4.3.1 Hematopoietic Stem Cells Market, 2010 – 2018 (USD Billion)
      4.3.2 Mesenchymal Stem Cells Market, 2010 – 2018 (USD Billion)
      4.3.3 Neuronal Stem Cells Market, 2010 – 2018 (USD Billion)
      4.3.4 Dental Stem Cells (Mesenchymal Stem Cells, Neuronal Stem Cells) Market, 2010 – 2018 (USD Billion)
      4.3.5 Umbilical Cord Stem Cells (Hematopoietic Stem Cells, Mesenchymal Stem Cells) Market, 2010 – 2018 (USD Billion)
4.4 Human Embryonic Stem Cells Market, 2010 – 2018 (USD Billion)
4.5 Induced Pluripotent Stem Cells Market, 2010 – 2018 (USD Billion)
4.6 Rat Neural Stem Cells Market, 2010 – 2018 (USD Billion)
4.7 Very Small Embryonic-Like Stem Cells Market, 2010 – 2018 (USD Billion)

Chapter 5 Global Stem Cells Market, By Technology
5.1 Market Segmentation: Global Stem Cells Market, By Technology
5.2 Overview
5.3 Global Stem Cell Acquisition Market, 2010 – 2018 (USD Billion)
      5.3.1 Global Bone Marrow Harvest for Stem Cells, 2010 – 2018 (USD Billion)
      5.3.2 Global Apheresis for Stem Cells Market, 2010 – 2018 (USD Billion)
      5.3.3 Global Umbilical Cord Blood Market, 2010 – 2018 (USD Billion)
5.4 Global Stem Cell Production Market, 2010 – 2018 (USD Billion)
      5.4.1 Global Therapeutic Cloning for Stem Cells Market, 2010 – 2018 (USD Billion)
      5.4.2 Global Stem Cells Production By In Vitro Fertilization Market, 2010 – 2018 (USD Billion)
      5.4.3 Global Stem Cell Isolation Market, 2010 – 2018 (USD Billion)
      5.4.4 Global Stem Cell Culture Market, 2010 – 2018 (USD Billion)
5.5 Global Stem Cell Cryopreservation Market, 2010 – 2018 (USD Billion)
5.6 Global Stem Cells Expansion and Sub-Culture Market, 2010 – 2018 (USD Billion)

Chapter 6 Global Stem Cells Market, By Application
6.1 Market Segmentation: Global Stem Cells Market, By Application
6.2 Overview
6.3 Global Stem Cells Market in Regenerative Medicine, 2010 – 2018 (USD Billion)
      6.3.1 Stem Cells Market in Neurology, 2010 – 2018 (USD Billion)
      6.3.2 Global Stem Cells Market in Orthopedics, 2010 – 2018 (USD Billion)
      6.3.3 Global Stem Cells Market in Oncology, 2010 – 2018 (USD Billion)
      6.3.4 Global Stem Cells Market in Hematology, 2010 – 2018 (USD Billion)
      6.3.5 Global Stem Cells Market for Cardiovascular and Myocardial Infarction, 2010 – 2018 (USD Billion)
      6.3.6 Global Stem Cells Market for Injuries, 2010 – 2018 (USD Billion)
               6.3.6.1 Global Stem Cells Market for Wound Care, 2010 – 2018 (USD Billion)
               6.3.6.2 Global Stem Cells Market for Spinal Cord Injuries, 2010 – 2018 (USD Billion)
               6.3.6.3 Global Stem Cells Market for Other (Joint Injuries, Eye Injuries, Lacerations and Concussions) Injuries, 2010 – 2018 (USD Billion)
      6.3.7 Global Stem Cells Market for Diabetes, 2010 – 2018 (USD Billion)
      6.3.8 Global Stem Cells Market for Liver Disorders, 2010 – 2018 (USD Billion)
      6.3.9 Global Stem Cells Market for Incontinence, 2010 – 2018 (USD Billion)
      6.3.10 Global Stem Cells Market for Other (Crohn’s Disease, Infertility, Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder) Regenerative Medicine Applications, 2010 – 2018 (USD Billion)
6.4 Global Stem Cells Market in Drug Discovery and Development, 2010 – 2018 (USD Billion)

Chapter 7 Global Stem Cells Market, By Geography
7.1 Overview
7.2 North America
      7.2.1 North America Stem Cells Market, 2010–2018 (USD Billion)
7.3 Europe
      7.3.1 Europe Stem Cells Market, 2010–2018 (USD Billion)
7.4 Asia
      7.4.1 Asia Stem Cells Market, 2010–2018 (USD Billion)
7.5 Rest of the World (Row)
      7.5.1 Row Stem Cells Market, 2010–2018 (USD Billion)

Chapter 8 Competitive Landscape
8.1 Heat Map Analysis for the Key Market Players
      8.1.1 Advanced Cell Technology Inc.
      8.1.2 STEMCELL Technologies Inc.
      8.1.3 Cellular Engineering Technologies Inc.
      8.1.4 Biotime Inc.
      8.1.5 Cellartis AB
8.2 Business Strategies for Success
      8.2.1 Focus on Research and Development
      8.2.2 Partnerships, Collaborations and Acquisitions

Chapter 9 Company Profiles
9.1 Advanced Cell Technology
      9.1.1 Company Overview
      9.1.2 Financial Overview
      9.1.3 Business Strategies
      9.1.4 Product Portfolio
      9.1.5 Recent Developments
9.2 Angel Biotechnology
      9.2.1 Company Overview
      9.2.2 Financial Overview
      9.2.3 Business Strategies
      9.2.4 Product Portfolio
      9.2.5 Recent Developments
9.3 Bioheart
      9.3.1 Company Overview
      9.3.2 Financial Overview
      9.3.3 Product Portfolio
      9.3.4 Business Strategies
      9.3.5 Recent Developments
9.4 Brainstorm Cell Therapeutics
      9.4.1 Company Overview
      9.4.2 Financial Overview
      9.4.3 Business Strategies
      9.4.4 Product Portfolio
      9.4.5 Recent Developments
9.5 California Stem Cell Inc.
      9.5.1 Company Overview
      9.5.2 Product Portfolio
      9.5.3 Business Strategies
      9.5.4 Recent Developments
9.6 Celgene Corporation Inc.
      9.6.1 Company Overview
      9.6.2 Financial Overview
      9.6.3 Business Strategies
      9.6.4 Product Portfolio
      9.6.5 Recent Developments
9.7 Cellartis AB
      9.7.1 Company Overview
      9.7.2 Business Strategies
      9.7.3 Product Portfolio
      9.7.4 Recent Developments
9.8 Cellular Engineering Technologies
      9.8.1 Company Overview
      9.8.2 Business Strategies
      9.8.3 Product Portfolio
      9.8.4 Recent Developments
9.9 Cytori Therapeutics Inc.
      9.9.1 Company Overview
      9.9.2 Financial Overview
      9.9.3 Product Portfolio
      9.9.4 Business Strategies
      9.9.5 Recent Developments
9.10 Biotime Inc.
      9.10.1 Company Overview
      9.10.2 Financial Overview
      9.10.3 Product Portfolio
      9.10.4 Business Strategies
      9.10.5 Recent Developments
9.11 Osiris Therapeutics
      9.11.1 Company Overview
      9.11.2 Financial Overview
      9.11.3 Product Portfolio
      9.11.4 Business Strategies
      9.11.5 Recent Developments
9.12 Stemcelltechnologies Inc.
      9.12.1 Company Overview
      9.12.2 Financial Overview
      9.12.3 Business Strategies
      9.12.4 Product Portfolio
      9.12.5 Recent Developments

List of Figures 

FIG. 1 Global Stem Cells Market, By Product Types, 2011 (USD Billion)
FIG. 2 Global Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 3 Porter’s Five Forces Analysis for the Global Stem Cells Market
FIG. 4 Market Attractiveness Analysis of the Stem Cells Market, By Geography
FIG. 5 Market Segmentation: Global Stem Cells Market, By Products
FIG. 6 Comparative Analysis of The Stem Cells Market, By Products, 2011 & 2018 (%)
FIG. 7 Comparative Analysis of Adult Stem Cells Market, By Products, 2011 & 2018 (%)
FIG. 8 Global Hematopoietic Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 9 Global Mesenchymal Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 10 Global Neuronal Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 11 Global Dental Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 12 Global Umbilical Cord Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 13 Global Human Embryonic Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 14 Global Induced Pluripotent Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 15 Global Rat Neural Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 16 Global Very Small Embryonic-Like Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 17 Market Segmentation: Global Stem Cells Market, By Technology
FIG. 18 Comparative Analysis of the Global Stem Cells Market, By Technology, 2011 & 2018 (%)
FIG. 19 Comparative Analysis of the Global Cell Acquisition Market, By Procedure, 2011 & 2018 (%)
FIG. 20 Global Bone Marrow Harvest for Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 21 Global Apheresis for Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 22 Global Umbilical Cord Blood Market, 2010 – 2018 (USD Billion)
FIG. 23 Comparative Analysis of the Stem Cell Production Market, By Procedures, 2011 & 2018 (%)
FIG. 24 Global Therapeutic Cloning for Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 25 Global Stem Cells Production By In Vitro Fertilization Market, 2010 – 2018 (USD Billion)
FIG. 26 Global Stem Cell Isolation Market, 2010 – 2018 (USD Billion)
FIG. 27 Global Stem Cell Culture Market, 2010 – 2018 (USD Billion)
FIG. 28 Global Stem Cell Cryopreservation Market, 2010 – 2018 (USD Billion)
FIG. 29 Global Stem Cells Expansion and Sub-Culture Market, 2010 – 2018 (USD Billion)
FIG. 30 Market Segmentation: Global Stem Cells Market, By Application
FIG. 31 Comparative Analysis of the Global Stem Cells Market, By Application, 2011 & 2018 (%)
FIG. 32 Comparative Analysis of Global Stem Cells Market in Regenerative Medicine, By Applications, 2011 & 2018 (%)
FIG. 33 Global Stem Cells Market in Neurology, 2010 – 2018 (USD Billion)
FIG. 34 Global Stem Cells Market in Orthopedics, 2010 – 2018 (USD Billion)
FIG. 35 Global Stem Cells Market in Oncology, 2010 – 2018 (USD Billion)
FIG. 36 Global Stem Cells Market in Hematology, 2010 – 2018 (USD Billion)
FIG. 37 Global Stem Cells Market for Cardiovascular and Myocardial Infarction, 2010 – 2018 (USD Billion)
FIG. 38 Comparative Analysis of Global Stem Cells in Injuries Market, 2011 & 2018 (%)
FIG. 39 Global Stem Cells Market for Wound Care, 2010 – 2018 (USD Billion)
FIG. 40 Global Stem Cells Market for Spinal Cord Injuries, 2010 – 2018 (USD Billion)
FIG. 41 Global Stem Cells Market for Other Injuries, 2010 – 2018 (USD Billion)
FIG. 42 Global Stem Cells in Diabetes Market, 2010 – 2018 (USD Billion)
FIG. 43 Global Stem Cells Market for Liver Disorders, 2010 – 2018 (USD Billion)
FIG. 44 Global Stem Cells Market for Incontinence, 2010 – 2018 (USD Billion)
FIG. 45 Global Stem Cells Market for Other Regenerative Medicine Applications, 2010 – 2018 (USD Billion)
FIG. 46 Global Stem Cells in Drug Discovery and Development Market, 2010 – 2018 (USD Billion)
FIG. 47 Comparative Analysis of the Global Stem Cells Market, By Geography, 2011 & 2018 (%)
FIG. 48 North America Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 49 Europe Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 50 Asia Stem Cells Market, 2010 – 2018 (USD Billion)
FIG. 51 Row Stem Cells Market, 2010 –2018 (USD Billion)
FIG. 52 Heat Map Analysis: Global Stem Cells Market
FIG. 53 Annual Sales of Advanced Cell Technology, 2009 – 2011 (USD Million)
FIG. 54 Annual Revenue of Angel Biotechnology, 2009 – 2011 (USD Million) (Conversion Rate: 1 GBP =1 .52 USD)
FIG. 55 Annual Sales of Bioheart Inc., 2009 – 2011 (USD)
FIG. 56 Annual Revenue of Celgene Corporation Inc., 2009 – 2011 (USD Million)
FIG. 58 Annual Sales of Biotime Inc, 2009 – 2011 (USD Million)
FIG. 60 Annual Sales of Neostem Inc., 2009 – 2011 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Stem Cells Market
TABLE 2 Global Stem Cells Market, By Products, 2010 – 2018 (USD Billion)
TABLE 3 Impact Analysis of the Market Drivers for Stem Cells Market
TABLE 4 Impact Analysis of the Market Restraints for Stem Cells Market
TABLE 5 Global Adult Stem Cells Market, By Products, 2010 – 2018 (USD Billion)
TABLE 6 Global Stem Cells Market, By Technology, 2010 – 2018 (USD Billion)
TABLE 7 Global Cell Acquisition Market, By Procedure, 2010 – 2018 (USD Billion)
TABLE 8 Global Stem Cells Market In Regenerative Medicine, By Applications, 2010 – 2018 (USD Billion)
TABLE 9 Global Stem Cells Market for Injuries, By Applications, 2010 – 2018 (USD Billion)
TABLE 10 Global Stem Cells Market, By Geography, 2010–2018 (USD Billion)

Enquiry Before Buying




Free Market Analysis




Stem cells are undifferentiated cells which are capable of differentiating into any type of cell that make up the human body, and thus are capable of producing the cells which are non-regenerative in nature. The global stem cells market is primarily driven by considerable therapeutic research activities, development of medical tourism hubs, and growing stem cell banking services. 

The global stem cells market by products is classified into five categories, namely adult stem cells, human embryonic stem cells, induced pluripotent stem cells, rat-neural stem cells and umbilical cord stem cells. Adult stem cells held majority share of the overall stem cells market by products in 2011, owing to less tedious procedure of adult stem cell harvesting, and better acceptance by the human body. Adult stem cells market is further segmented into five sub-types, viz. hematopoietic stem cells, mesenchymal stem cells, neuronal stem cells, dental stem cells, and umbilical cord stem cells. Neuronal stem cells will grow at the fastest pace during the forecast period amongst the adult stem cells segment, owing to rising proportions of patients with neurodegenerative diseases and consequently, growing urgency in developing curative treatment for such disorders. Induced pluripotent stem cells will be the fastest growing stem cell products in the forecast period. This is due to the fact that induced pluripotent stem cells causes less complications related to acceptance in the body. 

The stem cell acquisition market is the largest as well as the fastest growing stem cells market by technology. Stem cell acquisition is the primary step for obtaining stem cells from various sources such as bone marrow, umbilical cord and peripheral blood. Stem cells find applications in regenerative medicine as well as drug discovery and development. Regenerative medicine was the largest stem cells market by applications in 2011 and will maintain its leading position throughout the forecast period. Stem cell applications in regenerative neurology held major share of the market in 2011, due to the rising prevalence of neurological disorders and the quantum of research activities undertaken in this field.

On the basis of geography, the overall stem cells market is segmented into Asia, Europe, North America, and the rest of the world. The North America stem cells held majority of the market share in 2011. It was followed by Europe with a market share of over 25% in 2011. 

Some of the factors driving the North American stem cells market are listed below:
  • Stem cells provide therapeutic solutions for diseases with high prevalence in the U.S. such as cardiac and neurological disorders. According to the Centers for Disease Control and Prevention (CDC), the U.S., cardiac and malignant diseases causes more than 50% of deaths in the US every year. Moreover, the neurological disorders are also highly prevalent, owing to stressful lifestyle.
  • The provision of grants from organizations such as the National Institute of Health (NIH), California Institute for Regenerative Medicine (CIRM), New York Stem Cell Science, amongst other state initiatives have been encouraging for the research institutes to venture into stem cell research.
  • FDA has been authorized to provide orphan drug designations to many of the therapies developed for rare diseases such as Parkinson’s and Huntington’s using stem cells.
  • The US government has been encouraging the marketing of stem cells. According to the estimates presented at the New York Stem Cell Summit, 2012, the U.S. federal government itself was the largest purchaser of stem cell products in the same year.
Asian stem cells market is expected to show double digit growth during 2012 to 2018. Some of the drivers of the Asian stem cells market are rapidly growing medical tourism and contract research outsourcing market in this region. 

 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research